FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:1978-1988 May 6, 2004 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Cutaneous T-cell lymphoma represents a complex array of disorders with various manifestations, clinical courses, and therapeutic considerations. Mycosis fungoides — in which the skin is variably affected by flat patches, thin plaques, or tumors — is the most common form of cutaneous T-cell lymphoma; consequently, more is understood about it from a basic immunologic and molecular perspective than is understood about the other variants. The related Sézary syndrome is a more aggressive form of cutaneous T-cell lymphoma in which the skin is diffusely affected and there is measurable involvement within the peripheral blood. In addition to mycosis fungoides and the . . . [Full Text of this Article]

Clinical Features

Skin-Homing Capacity of Malignant Cells

T-Cell Activation

Clonal Dominance of T Cells

Conclusions

Source Information

From the Departments of Dermatology (M.G., P.W.H., L.D.W.) and Therapeutic Radiology (L.D.W.), Yale University School of Medicine, New Haven, Conn.

Address reprint requests to Dr. Wilson at the Department of Therapeutic Radiology, Yale University School of Medicine, HRT 136, 333 Cedar St., New Haven, CT 06520, or at lynn.wilson@yale.edu.

This article has been cited by other articles:

• Heald, P. (2009). "Cutaneous T-Cell Lymphoma": Cutaneous TNMania in Cutaneous Lymphomas. Arch Dermatol 145: 842-843 [Full Text]  
• Krejsgaard, T., Vetter-Kauczok, C. S., Woetmann, A., Kneitz, H., Eriksen, K. W., Lovato, P., Zhang, Q., Wasik, M. A., Geisler, C., Ralfkiaer, E., Becker, J. C., Odum, N. (2009). Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma. Blood 113: 5896-5904 [Abstract] [Full Text]  
• van Doorn, R., van Kester, M. S., Dijkman, R., Vermeer, M. H., Mulder, A. A., Szuhai, K., Knijnenburg, J., Boer, J. M., Willemze, R., Tensen, C. P. (2009). Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome. Blood 113: 127-136 [Abstract] [Full Text]  
• Chong, B. F., Wilson, A. J., Gibson, H. M., Hafner, M. S., Luo, Y., Hedgcock, C. J., Wong, H. K. (2008). Immune Function Abnormalities in Peripheral Blood Mononuclear Cell Cytokine Expression Differentiates Stages of Cutaneous T-Cell Lymphoma/Mycosis Fungoides. Clin. Cancer Res. 14: 646-653 [Abstract] [Full Text]  
• Yano, H., Ishida, T., Inagaki, A., Ishii, T., Ding, J., Kusumoto, S., Komatsu, H., Iida, S., Inagaki, H., Ueda, R. (2007). Defucosylated Anti CC Chemokine Receptor 4 Monoclonal Antibody Combined with Immunomodulatory Cytokines: A Novel Immunotherapy for Aggressive/Refractory Mycosis Fungoides and Sezary Syndrome. Clin. Cancer Res. 13: 6494-6500 [Abstract] [Full Text]  
• Huang, K. P., Weinstock, M. A., Clarke, C. A., McMillan, A., Hoppe, R. T., Kim, Y. H. (2007). Second Lymphomas and Other Malignant Neoplasms in Patients With Mycosis Fungoides and Sezary Syndrome: Evidence From Population-Based and Clinical Cohorts. Arch Dermatol 143: 45-50 [Abstract] [Full Text]  
• Cabrera, P. V., Amano, M., Mitoma, J., Chan, J., Said, J., Fukuda, M., Baum, L. G. (2006). Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death. Blood 108: 2399-2406 [Abstract] [Full Text]  
• Yamanaka, K.-i., Clark, R., Dowgiert, R., Hurwitz, D., Shibata, M., Rich, B. E., Hirahara, K., Jones, D. A., Eapen, S., Mizutani, H., Kupper, T. S. (2006). Expression of Interleukin-18 and Caspase-1 in Cutaneous T-Cell Lymphoma. Clin. Cancer Res. 12: 376-382 [Abstract] [Full Text]